The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

Drug manufacturers' use of AI has recently increased significantly, according to the FDA. Here's how the agency says the ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced technologies.

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while ...

Oxford Drug Design’s lead compound demonstrated statistically significant anti-tumour activity with efficacy comparable to that of rapamycin.